EPS for Walgreens Boots Alliance Inc (WBA) Expected At $1.22

Andrew Cummings
October 11, 2017

Company shares are trading at $70.87 which is much lower than the 50 day moving average of $79.74 and which is well below the 200 day moving average of $81.04.

Based on the latest brokerage notes which have been released to investors, 9 brokers have issued a rating of "strong buy", 8 brokers "buy", 8 brokers "neutral", 0 brokers "sell" and 0 brokers "strong sell".

Among new and sold out positions, 87 holders initiated new positions by a total of 5.81 million shares and 82 holders exited their positions by a total of 5.13 million shares.

Institutional investors have also been busy with the stock. At the time of writing, the 14-day ADX for Walgreens Boots Alliance (WBA) is 30.73. Following volatility data can help measure how much the stock price has fluctuated over the specified time period.


03/22/2017 - Walgreens Boots Alliance, Inc. had its "buy" rating reiterated by analysts at Deutsche Bank. MCF Advisors LLC now owns 1,923 shares of the pharmacy operator's stock worth $160,000 after purchasing an additional 780 shares during the last quarter. RES has risen 7.52% in the 1-month period. Teacher Retirement System of Texas grew its holdings in Walgreens Boots Alliance by 2.7% in the second quarter. Overall, the share price is down -14.37% year to date. These inputs included a growing difference between net income and cash flow from operations, increasing receivable days, growing day's sales of inventory, increasing other current assets, decrease in depreciation relative to gross property plant and equipment, and high total asset growth. Sound Shore Management Inc. After a long term look, we can observe that the current signal is Attractive for investors. A ratio over one indicates an increase in share price over the period.

Checking in on some valuation rankings, Walgreens Boots Alliance, Inc. They issued a "buy" rating and a $95.00 target price for the company.

Investors wait Walgreens Boots Alliance Inc (NASDAQ:WBA) to report on October, 19. its quarterly earnings Wall Street analysts expect $1.22 EPS, up $0.15 or 14.02 % from last year's $1.07 same quarter earnings. BidaskClub downgraded shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating in a report on Tuesday, September 12th. Credit Suisse maintained the stock with "Outperform" rating in Monday, November 16 report. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have assigned a buy rating to the stock. The company presently has an average rating of "Buy" and a consensus target price of $91.31. Other officers which have joined Kathleen Wilson-thompson in selling shares include William Foote who sold for 2736 shares. The stock was sold at an average price of $79.79, for a total transaction of $218,305.44.

A ratio of a publicly-traded company's book value to its market value. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.


COPYRIGHT VIOLATION NOTICE: "Pinnacle Financial Partners Inc". Walgreens Boots Alliance, Inc. declared a dividend for shareholders that was paid on Tue Sep 12, 2017. Walgreens Boots Alliance accounts for approximately 1.9% of Macguire Cheswick & Tuttle Investment Counsel LLC's investment portfolio, making the stock its 21st biggest position. (NASDAQ:WBA) has gathered pace in recent weeks as a result of the underlying changes in the state of insider activity.

Checking in on some valuation rankings, Walgreens Boots Alliance, Inc.

The company now has a P/E ratio of 17.90 and the market cap of the company is 75.84B. This buyback authorization permits the pharmacy operator to repurchase up to 5.9% of its shares through open market purchases. Typically, the lower the value, the more undervalued the company tends to be. Stockholders of record on Friday, August 18th were given a $0.40 dividend. The dividend was $0.400 per share for the quarter which comes to $1.60 on an annualized basis. This is a boost from Walgreens Boots Alliance's previous quarterly dividend of $0.38.

Performance Evaluation of Walgreens Boots Alliance, Inc. The Company is a global pharmacy-led, health and wellbeing enterprise. The Firm operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company's products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).


Other reports by iNewsToday

FOLLOW OUR NEWSPAPER